Pfizer to Slash Drug Prices in 2026 via TrumpRx, Saving Millions
Pfizer has announced significant discounts on its prescribed drugs, set to begin in 2026. The move, which will see certain medications sold at reduced prices to both Medicaid recipients and all consumers via an online platform called TrumpRx, is expected to save taxpayers and consumers hundreds of millions of dollars.
President Donald Trump first announced the discounts in 2018, aiming to lower medication costs in the United States, which has historically paid more for drugs than other countries. The discounts will apply to some of Pfizer's most popular medications, making them more affordable for a wider range of consumers.
The transfer of discounted prices will occur through a direct-to-consumer platform, TrumpRx, which will align with Medicaid pricing adjustments. This means that not only will Medicaid recipients benefit, but all consumers will have access to these reduced prices when purchasing medications online.
Pfizer's decision to offer discounted prices on its prescribed drugs is a significant step towards lowering medication costs in the United States. With the discounts set to begin in 2026 and available to both Medicaid recipients and all consumers via the TrumpRx platform, this move is expected to result in substantial savings for both taxpayers and consumers.
